Rapamycin Overproduction by Combined Mutational Study

Author(s): Subhasish Dutta*, Apurba Dey.

Journal Name: Current Biochemical Engineering

Volume 6 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: It is a great challenge for scientists to overcome the barrier of Antibiotic resistance by imparting new technologies to form structurally unique and robust antibiotics in an economically scalable way. Rapamycin is a well-known macrolide with numerous applications in the medical field. It is one of the most effective and efficient immunosuppressant antibiotic available in recent history. With the increase of its application, decreasing its production cost stands as one of the most critical challenges. Therefore, the selection of a suitable and potent strain of higher yield has emerged to be of great necessity in the present scenario.

Methods: Spores prepared from lyophilised culture when treated with different exposure to UV light, showed a decrease in survival rates in comparison to the untreated sample. Combined treatment of spores with UV mutagenesis and chemical mutagen (NTG) was done. Spores were incubated at 30°C at 120 rpm for 2 hr, and some of them were found viable after the treatment. Agar-disc diffusion method, turbidimetric assay and HPLC analysis were carried out to study the rapamycin concentration by potent strain.

Results: Macrolide production was seen to be maximum on the 11th day of fermentation which is 1.76 folds higher as compared to wild type Streptomyces hygroscopicus in shake flask. Structural confirmation and conformation study were supported by the Nuclear Magnetic Resonance (NMR) technique.

Conclusion: The maximum amount of antibiotic produced was observed to be 284 mg/L.

Keywords: Rapamycin, combined mutational study, Streptomyces hygroscopicus, NMR, HPLC, antibiotic resistance.

[1]
S.B. Zaman, M.A. Hussain, R. Nye, V. Mehta, K.T. Mamun, and N. Hossain, "A review on antibiotic resistance: alarm bells are ringing", Cureus, vol. 9, no. 6, 2017.e1403
[http://dx.doi.org/10.7759/cureus.1403] [PMID: 28852600]
[2]
P.A. Gruppuso, J.M. Boylan, and J.A. Sanders, "The physiology and pathophysiology of rapamycin resistance: implications for cancer", Cell Cycle, vol. 10, no. 7, pp. 1050-1058, 2011.
[http://dx.doi.org/10.4161/cc.10.7.15230] [PMID: 21389767]
[3]
C. Vézina, A. Kudelski, and S.N. Sehgal, "Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle", J. Antibiot. (Tokyo), vol. 28, no. 10, pp. 721-726, 1975.
[http://dx.doi.org/10.7164/antibiotics.28.721] [PMID: 1102508]
[4]
Y.R. Cheng, L. Hauck, and A.L. Demain, "Phosphate, ammonium, magnesium and iron nutrition of Streptomyces hygroscopicus with respect to rapamycin biosynthesis", J. Ind. Microbiol., vol. 14, no. 5, pp. 424-427, 1995.
[http://dx.doi.org/10.1007/BF01569962] [PMID: 7612217]
[5]
Y. Chen, "New process control strategy used in a rapamycin fermentation", Process Biochem., vol. 34, no. 4, pp. 383-389, 1999.
[http://dx.doi.org/10.1016/S0032-9592(98)00108-3]
[6]
L.A.R. Sallam, A.F. El-Refai, M.E. Osman, A.A. Hamdy, E.M. Ahmed, and M.A. Mohamed, "Some physiological factors affecting rapamycin production by Streptomyces hygroscopicus ATCC 29253", J. Am. Sci., vol. 6, no. 6, pp. 188-194, 2010.
[7]
S. Dutta, B. Basak, B. Bhunia, A. Sinha, and A. Dey, "Approaches towards the enhanced production of Rapamycin by Streptomyces hygroscopicus MTCC 4003 through mutagenesis and optimization of process parameters by Taguchi orthogonal array methodology", World J. Microbiol. Biotechnol., vol. 33, no. 5, p. 90, 2017.
[http://dx.doi.org/10.1007/s11274-017-2260-3] [PMID: 28390015]
[8]
S. Dutta, B. Basak, B. Bhunia, S. Chakraborty, and A. Dey, "Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003", 3 Biotech.vol. 4, no. 5, pp. 523-531, 2014,
[http://dx.doi.org/10.1007/s13205-013-0189-2]
[9]
S. Dutta, B. Basak, B. Bhunia, and A. Dey, "Bioprocess engineering aspects of rapamycin (Sirolimus) production: A review on past achievements and recent perspectives", J. Bioprocess Eng. Biorefinery, vol. 3, no. 4, pp. 243-256, 2014.
[http://dx.doi.org/10.1166/jbeb.2014.1105]
[10]
S. Dutta, B. Bhunia, A. Raju, N. Maity, and A. Dey, "Enhanced rapamycin production through kinetic and purification studies by mutant strain of Streptomyces hygroscopicus NTG-30-27", Chem. Pap., pp. 1-11, 2019.
[http://dx.doi.org/10.1007/s11696-019-00767-0]
[11]
I. Kojima, Y.R. Cheng, V. Mohan, and A.L. Demain, "Carbon source nutrition of rapamycin biosynthesis in Streptomyces hygroscopicus", J. Ind. Microbiol., vol. 14, no. 6, pp. 436-439, 1995.
[http://dx.doi.org/10.1007/BF01573954] [PMID: 7662284]
[12]
M.S. Lee, I. Kojima, and A.L. Demain, "Effect of nitrogen source on biosynthesis of rapamycin by Streptomyces hygroscopicus", J. Ind. Microbiol. Biotechnol., vol. 19, no. 2, pp. 83-86, 1997.
[http://dx.doi.org/10.1038/sj.jim.2900434] [PMID: 9366089]
[13]
H. Kessler, R. Haessner, and W. Schüler, "Structure of rapamycin: An NMR and molecular-dynamics investigation", Helv. Chim. Acta, vol. 76, no. 1, pp. 117-130, 1993.
[http://dx.doi.org/10.1002/hlca.19930760106]
[14]
J.A. Findlay, and L. Radics, "On the chemistry and high field nuclear magnetic resonance spectroscopy of rapamycin", Can. J. Chem., vol. 58, no. 6, pp. 579-590, 1980.
[http://dx.doi.org/10.1139/v80-090]
[15]
Z.N. Xu, W.H. Shen, X.Y. Chen, J.P. Lin, and P.L. Cen, "A high-throughput method for screening of rapamycin-producing strains of Streptomyces hygroscopicus by cultivation in 96-well microtiter plates", Biotechnol. Lett., vol. 27, no. 15, pp. 1135-1140, 2005.
[http://dx.doi.org/10.1007/s10529-005-8463-y] [PMID: 16132865]
[16]
L. Dang, J. Liu, C. Wang, H. Liu, and J. Wen, "Enhancement of rapamycin production by metabolic engineering in Streptomyces hygroscopicus based on genome-scale metabolic model", J. Ind. Microbiol. Biotechnol., vol. 44, no. 2, pp. 259-270, 2017.
[http://dx.doi.org/10.1007/s10295-016-1880-1] [PMID: 27909940]
[17]
C. Wang, J. Wang, J. Yuan, L. Jiang, X. Jiang, B. Yang, G. Zhao, B. Liu, and D. Huang, "Generation of Streptomyces hygroscopicus cell factories with enhanced ascomycin production by combined elicitation and pathway-engineering strategies", Biotechnol. Bioeng., vol. 116, no. 12, pp. 3382-3395, 2019.
[http://dx.doi.org/10.1002/bit.27158] [PMID: 31478187]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 6
ISSUE: 1
Year: 2020
Page: [62 - 67]
Pages: 6
DOI: 10.2174/2212711906666191127095557
Price: $58

Article Metrics

PDF: 10
HTML: 1